Nilesh Kumar

1.2k total citations
58 papers, 665 citations indexed

About

Nilesh Kumar is a scholar working on Ophthalmology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nilesh Kumar has authored 58 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Ophthalmology, 23 papers in Immunology and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nilesh Kumar's work include Retinal Diseases and Treatments (25 papers), Biosimilars and Bioanalytical Methods (17 papers) and Retinal Imaging and Analysis (12 papers). Nilesh Kumar is often cited by papers focused on Retinal Diseases and Treatments (25 papers), Biosimilars and Bioanalytical Methods (17 papers) and Retinal Imaging and Analysis (12 papers). Nilesh Kumar collaborates with scholars based in United States, India and Israel. Nilesh Kumar's co-authors include Ashish Sharma, Francesco Bandello, Baruch D. Kuppermann, Nikulaa Parachuri, Anat Loewenstein, Anat Loewenstein, Carl D. Regillo, Rohini Sharma, Taruna Madan and David S. Boyer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Vision Research and American Journal of Ophthalmology.

In The Last Decade

Nilesh Kumar

56 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nilesh Kumar United States 15 493 334 117 106 42 58 665
Nuno Alves Portugal 8 129 0.3× 106 0.3× 11 0.1× 50 0.5× 16 0.4× 20 322
Yingjie Ma China 12 69 0.1× 18 0.1× 25 0.2× 58 0.5× 6 0.1× 30 304
R Streuli Switzerland 12 11 0.0× 35 0.1× 44 0.4× 111 1.0× 16 0.4× 40 412
Ernestini Giziaki Greece 5 91 0.2× 12 0.0× 58 0.5× 34 0.3× 175 4.2× 5 306
Kiyomi Koike Japan 8 11 0.0× 20 0.1× 13 0.1× 32 0.3× 10 0.2× 27 225
Kazuhito Fukuoka Japan 8 13 0.0× 8 0.0× 56 0.5× 60 0.6× 62 1.5× 23 216
Marilee Carballo United States 4 69 0.1× 178 0.5× 4 0.0× 33 0.3× 1 0.0× 4 314
B.R. Bacon United States 7 28 0.1× 13 0.0× 6 0.1× 34 0.3× 21 0.5× 15 360
Catarina Schiborn Germany 6 11 0.0× 29 0.1× 45 0.4× 89 0.8× 4 0.1× 10 191

Countries citing papers authored by Nilesh Kumar

Since Specialization
Citations

This map shows the geographic impact of Nilesh Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nilesh Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nilesh Kumar more than expected).

Fields of papers citing papers by Nilesh Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nilesh Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nilesh Kumar. The network helps show where Nilesh Kumar may publish in the future.

Co-authorship network of co-authors of Nilesh Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Nilesh Kumar. A scholar is included among the top collaborators of Nilesh Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nilesh Kumar. Nilesh Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Ashish, Se Joon Woo, Christopher S. Lee, et al.. (2025). Aflibercept 2 mg biosimilars—will they lead the Anti-VEGF biosimilar world globally. Eye. 39(6). 1026–1027. 1 indexed citations
2.
Sharma, Ashish, et al.. (2022). Ranizurel safety evaluation in real-world -(RaSER) study. American Journal of Ophthalmology Case Reports. 25. 101358–101358. 6 indexed citations
3.
Sharma, Ashish, Nikulaa Parachuri, Nilesh Kumar, Francesco Bandello, & Baruch D. Kuppermann. (2022). Biosimilar anti-VEGF—Yardsticks to ensure biosimilarity. Eye. 37(1). 4–5. 1 indexed citations
4.
Sharma, Ashish, et al.. (2021). Semaglutide and the risk of diabetic retinopathy—current perspective. Eye. 36(1). 10–11. 29 indexed citations
5.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2021). Ranibizumab Biosimilar (Razumab) vs Innovator Ranibizumab (Lucentis) in neovascular age-related macular degeneration (n-AMD)- efficacy and safety (BIRA study). Eye. 36(5). 1106–1107. 13 indexed citations
6.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2021). Understanding the Mechanisms of Fluid Development in Age-Related Macular Degeneration. Ophthalmology Retina. 5(2). 105–107. 8 indexed citations
7.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2021). Brolucizumab—foreseeable workflow in the current scenario. Eye. 35(6). 1548–1550. 14 indexed citations
8.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2020). Brolucizumab—early real-world experience: BREW study. Eye. 35(4). 1045–1047. 55 indexed citations
9.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2020). Correction: Brolucizumab—early real-world experience: BREW study. Eye. 35(4). 1286–1286. 2 indexed citations
10.
Sheth, Jay, Giridhar Anantharaman, Nilesh Kumar, et al.. (2020). Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum. Eye. 34(9). 1501–1503. 11 indexed citations
11.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2020). Brolucizumab and immunogenicity. Eye. 34(10). 1726–1728. 41 indexed citations
12.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2019). Ranibizumab port delivery system (RPDS): realising long awaited dream of prolonged VEGF suppression. Eye. 34(3). 422–423. 9 indexed citations
13.
Sharma, Ashish, Nilesh Kumar, Baruch D. Kuppermann, Francesco Bandello, & Anat Loewenstein. (2019). Faricimab: expanding horizon beyond VEGF. Eye. 34(5). 802–804. 58 indexed citations
14.
Sharma, Ashish, Nilesh Kumar, Baruch D. Kuppermann, Francesco Bandello, & Anat Loewenstein. (2019). Ophthalmic biosimilars and biologics—role of endotoxins. Eye. 34(4). 614–615. 14 indexed citations
15.
Sharma, Ashish, Nilesh Kumar, Francesco Bandello, Anat Loewenstein, & Baruch D. Kuppermann. (2019). Need of education on biosimilars amongst ophthalmologists: combating the nocebo effect. Eye. 34(6). 1006–1007. 15 indexed citations
16.
Sharma, Ashish, Nilesh Kumar, Baruch D. Kuppermann, Francesco Bandello, & Anat Loewenstein. (2019). Biotherapeutics and immunogenicity: ophthalmic perspective. Eye. 33(9). 1359–1361. 22 indexed citations
17.
Sharma, Ashish, Nilesh Kumar, Baruch D. Kuppermann, Anat Loewenstein, & Francesco Bandello. (2019). Brolucizumab: is extended VEGF suppression on the horizon?. Eye. 34(3). 424–426. 6 indexed citations
18.
Meena, Lokesh Kumar, et al.. (2013). Association of serum uric acid and microalbuminuria in prehypertension : A cross sectional study. National Journal of Physiology Pharmacy and Pharmacology. 3(1). 87–87. 3 indexed citations
19.
Kumar, Nilesh, et al.. (2012). AN UNUSUAL SURVIVAL IN A CASE OF CELPHOS POISONING. SHILAP Revista de lepidopterología. 2(4). 518–519. 1 indexed citations
20.
Kumar, Nilesh, et al.. (2012). Primary Angiitis of Central Nervous System. SHILAP Revista de lepidopterología. 2(4). 523–525. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nuno Alves Breakdown of academic impact, for papers by Yingjie Ma Breakdown of academic impact, for papers by R Streuli Breakdown of academic impact, for papers by Ernestini Giziaki Breakdown of academic impact, for papers by Kiyomi Koike Breakdown of academic impact, for papers by Kazuhito Fukuoka Breakdown of academic impact, for papers by Marilee Carballo Breakdown of academic impact, for papers by B.R. Bacon Breakdown of academic impact, for papers by Catarina Schiborn
Rankless by CCL
2026